Spikevax

Spikevax, formerly Moderna covid-19 vaccine or MRNA-1273, is Moderna's is vaccine against the covid-19.

External

 * EMA, Spikevax (previously covid-19 Vaccine Moderna)

News

 * 23 Jul 2021, Politico.eu, EU regulator OKs Moderna vaccine for teens, Data showed the Moderna jab produced a comparable antibody response in 12- to 17-year-olds as it did in young adults.
 * 07 Jun 2021, Politico.eu, Moderna applies for EU coronavirus vaccine authorization covering teens, Two doses were shown to be 100 percent effective at preventing illness in a 2,500-participant trial.
 * 02 Jun 2021, Politico.eu, Moderna to double EU vaccine manufacturing with new Dutch site, In total, Moderna expects to make 600 million doses a year in the EU.
 * 01 Jun 2021, Politico.eu, Moderna seeks full approval of its coronavirus vaccine from US regulator, The green light would allow the company to market the shot directly to consumers.
 * 03 May 2021, Politico.eu, Moderna commits up to 500M vaccine doses to Covax, Under the deal, Moderna will work with Gavi, the Vaccine Alliance, to supply 34 million doses to Covax in late 2021.
 * 01 May 2021, Politico.eu, WHO lists Moderna vaccine for emergency use, The listing is a prerequisite for Covax use.
 * 29 Apr 2021, Reuters.com, Moderna boosting covid-19 vaccine capacity, targets up to 3 billion shots in 2022
 * 06 Apr 2021, Politico.eu, First doses of Moderna vaccine arrive in UK, The jab might play a crucial role in the UK’s inoculation campaign. The vaccine is coming from the company's European supply chain, including Switzerland, Spain and France. The vaccine is also made in the U.S., but vaccine exports are currently not allowed.
 * 07 Mar 2021, Politico.eu, 16 EU countries opted against Moderna vaccine top-up: Hungarian government, According to the document, 16 countries opted out of the vaccine top-up, including: Poland, Romania, Belgium, Greece, the Czech Republic, Bulgaria, Slovakia, Ireland, Lithuania, Slovenia, Latvia, Estonia, Cyprus, Luxembourg and Malta.
 * 07 Jan 2021, Reuters.com, Moderna CEO says vaccine likely to protect for 'couple of years'